IFF Elects Dr. Li-Huei Tsai to Board of Directors
31 October 2019 - 7:15AM
Business Wire
Regulatory News:
IFF (NYSE: IFF) (Euronext Paris: IFF) (TASE: IFF), a leading
innovator of taste, scent, nutrition, announced that Dr. Li-Huei
Tsai, Picower Professor and Director of the Picower Institute for
Learning and Memory at the Massachusetts Institute of Technology,
was elected to the Company's Board of Directors, effective
immediately. Dr. Tsai will also be a member of the Company’s
Compensation Committee.
“Dr. Tsai is an exceptionally talented individual and we’re
pleased she is joining IFF’s Board,” said IFF Chairman and CEO
Andreas Fibig. “Her experience will be incredibly valuable to our
innovation and R&D activities. We believe her scientific
knowledge will complement the talent we currently have among our
directors and add diversity of viewpoint and background,
strengthening our Company.”
Dr. Tsai was named Director of the Picower Institute for
Learning and Memory in June 2009. She is responsible for overseeing
the activities and research initiatives of the center, and leading
the many scientists dedicated to understanding the mechanisms that
drive learning and memory. During her 10-year tenure, Dr. Tsai has
been cited as a pioneer in the field of Alzheimer’s research and
her efforts have earned her numerous awards.
Dr. Tsai is co-founder of Cognito Therapeutics, a company
focused on developing a device-based approach to treating
Alzheimer’s. She is a member of the Broad Institute, launched in
2004 to improve human health and lay a foundation for a new
generation of therapies. Previously, Dr. Tsai was an investigator
at Howard Hughes Medical Institute and she served as a Professor in
the Department of Pathology at Harvard Medical School from 1994 to
2006.
Dr. Tsai received her Ph.D degree from the University of Texas
Southwestern Medical Center at Dallas, and postdoctoral training at
Cold Spring Harbor Laboratory and Massachusetts General
Hospital.
Welcome to IFF
At IFF (NYSE:IFF) (Euronext Paris: IFF) (TASE: IFF), we’re using
Uncommon Sense to create what the world needs. As a collective of
unconventional thinkers and creators, we put science and artistry
to work to create unique and unexpected scents, tastes, experiences
and ingredients for the products our world craves. Learn more at
iff.com, Twitter , Facebook, Instagram, and LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191030005590/en/
Michael DeVeau Head of Investor Relations and Communications
& Divisional CFO, Scent 212.708.7164 Michael.DeVeau@iff.com